Severe Hypocalcemia

The FDA cleared a wearable vibration belt to treat postmenopausal women with osteopenia, according to an industry press release.

The FDA has added a boxed warning for denosumab to advise patients with advanced chronic kidney disease of an increased risk for severe hypocalcemia, according to an FDA drug safety communication.